Patient Satisfaction With Propofol for Out Patient Colonoscopy

NCT ID: NCT02937506

Last Updated: 2017-12-26

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this study is to determine if patient satisfaction with propofol is better than with non-propofol anesthesia for outpatient colonoscopies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Outpatient colonoscopies are very common, indicated for various reasons, and are more commonly performed in outpatient surgery or endoscopy centers. There is an increase in the use of propofol for sedation because of the short duration of action and quick turn around time. Propofol has been studied extensively for safety and efficacy but patient satisfaction and preference with use has not been well documented in prospective, randomized setting. In the context of the recent changes in healthcare reimbursement where patient satisfaction is becoming an important metric providing data that could improve patient satisfaction is needed.

Patients who presented for a colonoscopy with the Principal Investigator were approached to participate in the study. After obtaining consent the patients were randomized to anesthesia with propofol or control without propofol per random number tables provided by the statistician. The anesthesiologist or nurse anesthetist were asked to remove the paper with the assignment from the envelope to determine which medications to give the patient. Pre-op, intra-op, and post-op data were collected by registered nurses blinded to the anesthetic. The day one follow-up phone call was made by the resident who was blinded to the anesthetic. Data were collected in the pre-op, intra-op, and post-op areas by the researchers who were blinded to the medications used.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Cancer IBS Polyps

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

propofol colonoscopy patient satisfaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Propofol

Patients in the treatment arm will be given propofol only when having a colonoscopy.

Group Type EXPERIMENTAL

Propofol

Intervention Type DRUG

The intervention is to use propofol as anesthesia during a colonoscopy.

Fentanyl Plus Midazolam Only

Patients in the control arm will receive only the standard of care medications, fentanyl and midazolam when having a colonoscopy.

Group Type EXPERIMENTAL

Fentanyl Plus Midazolam

Intervention Type DRUG

The control is to use standard of care anesthesia, fentanyl and midazolam, during a colonoscopy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Propofol

The intervention is to use propofol as anesthesia during a colonoscopy.

Intervention Type DRUG

Fentanyl Plus Midazolam

The control is to use standard of care anesthesia, fentanyl and midazolam, during a colonoscopy.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Diprivan Sublimaze Versed

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patients having an outpatient colonoscopy

Exclusion Criteria

\- High risk patients (ASA IV \& V) who are not candidates for colonoscopy in an outpatient center will be excluded.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mount Carmel Health System

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anantha Padmanabhan, MD

Role: PRINCIPAL_INVESTIGATOR

Mount Carmel Health System

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mount Carmel Health System

Columbus, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

131115-3

Identifier Type: -

Identifier Source: org_study_id